Lechleiter Appointed to IBRI Board

John Lechleiter

Listen to this story

Subscriber Benefit

As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe Now

This audio file is brought to you by

0:00

0:00

Loading audio file, please wait.

Speed
1.00

• 0.25
• 0.50
• 0.75
• 1.00
• 1.25
• 1.50
• 1.75
• 2.00

The Indiana Biosciences Research Institute has appointed former Eli Lilly and Co. Chairman, President and CEO John Lechleiter to its board of directors. He retired from Lilly in 2016 and served as chairman of the board of directors from January 2009 to May 2017. Lechleiter joined Lilly in 1979 as a senior organic chemist, working his way from the lab to global leadership.

He earned a bachelor’s degree in chemistry from Xavier University and master’s and doctoral degrees in organic chemistry from Harvard University. Lechleiter has received honorary doctorates from Marian University, the University of Indianapolis, the National University of Ireland, Indiana University, Franklin College, Butler University and Purdue University.

He is a member of the American Chemical Society. Lechleiter serves as vice chair of the board of the Science History Institute and is an emeritus member of the Central Indiana Corporate Partnership board. He also serves on the boards of Ford Motor Co., Indiana Economic Development Corp., Nike Inc. and United Way Worldwide.